ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

GSK Gsk Plc

1,705.00
32.00 (1.91%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  32.00 1.91% 1,705.00 1,701.00 1,701.50 1,718.50 1,673.00 1,685.50 5,853,296 16:35:27
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.21 70.03B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,673p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £70.03 billion. Gsk has a price to earnings ratio (PE ratio) of 14.21.

Gsk Share Discussion Threads

Showing 20776 to 20798 of 33125 messages
Chat Pages: Latest  833  832  831  830  829  828  827  826  825  824  823  822  Older
DateSubjectAuthorDiscuss
03/3/2020
13:43
AZN up nicely..this....
badtime
03/3/2020
12:23
Volumes picking up today, again ….. ;0)
tradermichael
03/3/2020
12:07
GBP 1.0 = USD 1.28
tradermichael
02/3/2020
20:44
GlaxoSmithKline Reportedly Trying to Sell Some of its Antibiotics Portfolio
philanderer
02/3/2020
15:45
Well earlier this afternoon there was a single big trade (purchase) of over 4 million shares …. 0)
tradermichael
02/3/2020
15:37
Is it the shorters coming back to roost?
abdullla
02/3/2020
15:33
Over 18 million shares traded today, so far ….. ;0
tradermichael
02/3/2020
13:28
Over 15 million shares traded today, so far ….. ;0
tradermichael
01/3/2020
10:20
Problem is big liquid stocks like Astra, Gsk get sold to pay for the losses of traders, hedgies leveraged up in long positions, so your winners have to be sold.
montyhedge
29/2/2020
15:06
Do you know if this going to be available in the UK?
gateside
29/2/2020
09:22
Lunacy …. I agree.

Meanwhile, GSK new submissions and approvals coming thick and fast:

FDA approves GSK's Advil Dual Action with Acetaminophen for over-the-counter use in the United States

Franck Riot, Head of R&D, GSK Consumer Healthcare said: "For decades, many consumers have been using ibuprofen and acetaminophen to get the benefits of both active ingredients when safely treating their headaches, muscle aches, backaches, arthritis and other joint pain. Now Advil, the No. 1 selling OTC pain reliever, will offer US consumers the first-ever alternative option -- a single, fixed-dose combination pain reliever.

As the world-leader in pain relief, Advil Dual Action and our recently FDA-approved Voltaren Arthritis Pain gel, demonstrates GSK's commitment to providing new safe, effective and convenient pain relief options for consumers."

Advil Dual Action provides relief for multiple symptoms and is the first formulation that combines ibuprofen and acetaminophen, two powerful ingredients indicated for OTC pain relief that work in different ways.

The submission in support of today's approval of Advil Dual Action was based on data from seven clinical studies, three of which were pivotal efficacy and safety studies in pain relief. The data supports a pain relief indication and demonstrates that the fixed-dose combination achieves superior efficacy compared to the individual monocomponents of ibuprofen (250mg) and acetaminophen (500mg) alone (as evidenced by appreciable improvements in acute pain symptoms across multiple pre-specified endpoints).

tradermichael
28/2/2020
15:29
Abdulla...whos borrowing? Im in, started building a position. This media driven lunacy will be over soon.
porsche1945
28/2/2020
12:57
You should avoid borrowing money to buy shares no matter what ..obviously!
badtime
28/2/2020
12:02
Don't panic ….. ;o)
tradermichael
28/2/2020
11:55
As long as Coronavirus is killing people the markets will continue to fall because it is a new disease with no cure and will have its day,we should avoid borrowing money to buy so called cheap shares.
abdullla
28/2/2020
10:49
Sub 1550 i will start to get in again, more people die of normal flu in two days than have died of coronavirus in two months, media driven over the top frenzy for idiots, I love it, great buying oppotunity.
porsche1945
28/2/2020
10:40
I hope we all live long to see better times ahead,Amin
abdullla
28/2/2020
09:39
Hi Abdulla, I don't see a catastrophe, i see a buying opportunity. My capital value overall may be down but i don't need to sell. It will recover by the time i need to dip into the capital although the plan is to live off the income. The div yield of stocks i want to buy is now much higher than a week ago, and the value they will pay me will be much the same this year as last. Lots of shares now have good looking P/E's
mr woodentop
28/2/2020
09:17
Every body once in their life time sees some sort of catastrophe maybe,God forbid,it is our turn now as nobody gets a free ride.
abdullla
27/2/2020
20:28
"Israeli Scientists Say They Will Have Coronavirus Vaccine "In A Few Weeks"


And on Thursday 27th Feb , a team of Israeli scientists one-upped the US, boasting that they could have a vaccine ready "in a few weeks.

According to a statement cited by the Jerusalem Post, a team of Israeli scientists are on the cusp of developing the first vaccine against the novel coronavirus, according to Israel's Science and Technology Minister, Ofir Akunis. If all goes as planned, the vaccine could be ready within a few weeks and available for human use in 90 days.

For four years, a team of scientists at MIGAL has been developing a vaccine to combat infectious bronchitis virus (IBV), which causes a bronchial disease affecting poultry. The effectiveness of the vaccine has been demonstrated during preclinical trials carried out at the Veterinary Institute.

During the process, they discovered a process for developing new vaccines that they expect will help facilitate a novel coronavirus vaccine in world-beating time.

crossing_the_rubicon
27/2/2020
10:33
Amazing how even after 14 years the ramping BS always sounds the same.. this is huge, going to blow, get in now, 10 bagger.. rinse and repeat (yawn). Going on to GSK this has shown a bit more resilience in the last few days, but can't help wondering if this is predicated in fairly unrealistic hopes that it will play a timely and significant part in delivering the Covid-19 vaccine
rikky72
27/2/2020
00:23
NCYT huge huge news.. going to go mental tomm

Corona virus spreading like mad..

NCYT most accurate kits on market right now and CE approval.


NCYT Their website just been updated with the following
Chinese Flag(Top Left)
1. WHO. World health organisation... don't get any bigger then this.. cats out the bag
2. Pfizer
3. GSK
4. NHS
5. CDC
6. US Army

jackjackpaul
26/2/2020
23:45
Gsk price has FA to do with Coronavirus, no exposure. Everything to do with Sales growth, debt, value post spin off. DYOR.
suresure
Chat Pages: Latest  833  832  831  830  829  828  827  826  825  824  823  822  Older

Your Recent History

Delayed Upgrade Clock